At the same time, the risk of being diagnosed with lung disease-which includes chronic bronchitis, emphysema, asthma, or chronic obstructive pulmonary disease (COPD)-was highest among adults who smoke cigarettes and vape, according to the researchers, who tracked study participants over three years. In the meantime, a study found that people who use only e-cigarettes increase their risk of developing lung disease by about 30% compared with nonusers. For adults using the devices to quit smoking, the advice is to “weigh all risks and benefits and consider using FDA-approved nicotine replacement therapies.” The CDC further warned against using any vaping products that contain THC buying devices from “informal sources, including friends and family” and modifying or adding substances to e-cigarettes. “E-cigarette use is never safe for youth, young adults, or pregnant women,” said CDC’s Dana Meaney-Delman, MD, who led the agency’s response to the 2019 outbreak. According to the CDC, 15% of EVALI patients were less than 18 years old. The 2019 outbreak of EVALI cases emerged against a backdrop of an ongoing vaping epidemic among youth. Researchers have also identified vitamin E acetate, a chemical added to some THC-containing vaping products, as the main-but possibly not the only-cause of the illness. Since the initial outbreak, federal and state officials have reported thousands of cases and dozens of deaths related to EVALI. Patients affected by the disease have symptoms ranging from cough, chest pain, and shortness of breath to fatigue, vomiting, diarrhea, weight loss, and fever. In 2019, the Centers for Disease Control and Prevention (CDC) advised people to avoid e-cigarettes while federal and state officials investigated an ongoing nationwide outbreak of severe lung injuries associated with the use of e-cigarette, or vaping, products. The condition came to be called “e-cigarette, or vaping, product use associated lung injury,” or EVALI. Why is there so much attention on vaping? In the applications, the manufacturers were instructed to demonstrate that their products were in the interest of public health. The agency originally had until that date to review approximately 6.5 million product applications from more than 500 companies. On September 9, the Food and Drug Administration (FDA) said it needs more time to decide whether e-cigarettes from Juul Labs and other manufacturers can remain on the U.S.
0 Comments
Leave a Reply. |
AuthorWrite something about yourself. No need to be fancy, just an overview. ArchivesCategories |